HF2906
IntroducedMNPsilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.
Minnesota · Session 2025
Status
Introduced
As of Mar 27, 2025
Last Action
Author added Rymer
Official Source
Official Full Bill TextSummary
A Minnesota bill, with an author recently added, would formally establish a psilocybin therapeutic use program including protections for registered patients, designated cultivators, registered facilitators, and health care practitioners, along with rulemaking authority, civil action provisions, fees, an advisory committee, criminal penalties, and appropriations. The comprehensive regulatory framework would define cultivation, testing, and facilitation requirements, shaping how businesses and practitioners may legally operate within the psilocybin therapeutic space.
What
A Minnesota bill, with an author recently added, would formally establish a psilocybin therapeutic use program including protections for registered patients, designated cultivators, registered facilitators, and health care practitioners, along with rulemaking authority, civil action provisions, fees, an advisory committee, criminal penalties, and appropriations.
Who
cultivators and labs and patients
Why
The comprehensive regulatory framework would define cultivation, testing, and facilitation requirements, shaping how businesses and practitioners may legally operate within the psilocybin therapeutic space.
Want to advertise here?
Get your business listed on buyweed.us
Want to advertise here?
Get your business listed on buyweed.us
More Minnesota Cannabis Bills
- SF4401Omnibus Cannabis billPassed
- SF4957Registered designated caregivers provisions modifications and increasing patient and cannabis plant limits expansion provisionIntroduced
- HF3615Cannabis laboratory testing requirements extended.Passed
- SF4877Cannabis license application periods and issuance modificationIntroduced
- SF4871Remediated cannabis product definitionIntroduced
- SF4876Cannabis microbusiness outdoor cultivation limit increaseIntroduced
- HF4733Remediated cannabis product defined, and cannabis business required to disclose information related to remediated cannabis products.Introduced
- SF4875Medical cannabis endorsement requirements modificationIntroduced
- HF4688Cannabis license holders allowed to transport products to testing facilities.Introduced
- HF4577Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.Introduced
- HF4570Cannabis microbusiness outdoor cultivation limit increased.Introduced
- SF4542Cannabis event provisions modificationIntroduced
LEGISLATIVE DATA PROVIDED BY LEGISCAN · LICENSED UNDER CC BY 4.0 · UPDATED Aug 18, 2026